Issa Yousif


Issa is a PhD student in the department of Bioengineering, working in the lab of Dr. David Baker. His research involves designing de novo protein therapeutics—specifically he is working to engineer protein based solutions for the problem of endosomal escape. Before starting his PhD, Issa worked in the Applications and R&D group at 10X Genomics, where he helped develop linked-read sequencing technology. He is interested in research commercialization. Issa received a B.S. in Biology with honors from Stanford University.

Richard Lee

VP of Development

Richard is a PhD student in the Department of Materials Science & Engineering at the University of Washington working in the lab of Dr. Mehmet Sarikaya (GEMSEC), and received his Bachelor's degree in Physiology & Neurobiology, and Molecular & Cell Biology from the University of Connecticut. He spent seven years in academic research studying neuroinflammation and stroke disease before starting graduate school. His current research focuses on developing biosensors for cancer diagnostics, for which he received an Amazon Catalyst grant to pursue this endeavor. His activities outside of the lab include serving as Chair on the UW College of Engineering Student Advisory Council where he was previously co-chair and the Facilities, Space and Capital Projects Subcommittee Lead. He has interests in entrepreneurship and technology commercialization and is open to exploring opportunities related to those areas. In his free time, Richard likes to weightlift and study foreign languages.

Fred Yeboah

Career Fair Coordinator

Fred is a PhD student in the Molecular and Cellular Biology Program, working in the lab of Dr. Jessica Young. His research focuses on using induced pluripotent stem cells (iPSCs) as a model to study Alzheimer’s Diseases and other age-related disease mechanisms. Fred received his bachelor’s degree from Alabama State University with honors and was awarded the 2015 George H. Andrew Student of the Year Award. Receiving a prestigious research fellowship from Novartis Institute for Biomedical Research, Fred spent two years conducting research after college before coming to UW. Fred is interested in technology commercialization, business strategy and entrepreneurship. Fred enjoys swimming and soccer during his leisure hours.

Dasom (Christine) Yoo

VP of Relations

Christine is a PhD student in the Bioengineering program, studying in the labs of Dr. Charles Murry and Dr. Michael Regnier. Her research is on using stem cell derived-cardiomyocytes to improve the heart function after a heart attack. Christine received her B.S. in Bioengineering at the University of Washington with departmental honors and conducted research in Dr. Patrick Stayton's lab, working on synthesis of polymeric nanoparticles to reduce oxidative stress in traumatic brain injury model. Throughout her academic career, Christine has served on various leadership roles such as VP of Biomedical Engineering Society at the University of Washington and student advisory board class representative. She is interested in exploring career paths beyond academia especially in life science business development and venture capital, and is passionate about bridging basic research and translational products. Outside of work, Christine enjoys spending time with her dog, traveling, and playing board games.

Joey Leal

VP of Networking

Joey is a PhD student in the Immunology program at UW South Lake Union in the lab of Dr. Michael Gerner. His research involves utilizing cutting edge microscopy techniques to dissect how different types of immune cells communicate to launch the immune response during vaccination and viral infection. Joey received his Bachelor of Science in Microbiology in 2014 from Arizona State University in Tempe, Arizona, where he was a National Institutes of Health Initiative for Maximizing Student Development (NIH IMSD) Scholar. He then went on to complete a post-baccalaureate NIH PREP fellowship at ASU. Joey is interested in the biotechnology industry related to discovery biology, business development, and venture capital.

Melissa MacEwen

VP of Membership

Melissa is a doctoral student in the University of Washington Department of Pharmacology working in the Sancak Lab. Her research currently focuses on mitochondrial signaling and calcium regulation -- research areas that have been implicated in diseases ranging from Alzheimer’s disease, to aging, to Parkinson’s disease. Melissa graduated from Tufts University with a double major in biology and English. Before joining the pharmacology department, she spent three years studying molecular botany at the University of Washington and working at a next-generation DNA sequencing startup. She is interested in entrepreneurship, sustainability, and life science business development. In her free time, Melissa enjoys hiking, foraging, and volunteering at Seattle’s Pacific Science Center.

Ashley Allison

VP of Marketing

Ashley Allison is a second-year undergraduate student in the University of Washington’s College of Engineering. With a passion for business and STEM, she is pursuing a degree in Industrial engineering to prepare for a career that can combine both worlds. After studying high tech industry and technology in Japan, she hopes to continue her work on projects that provide aid for disaster relief operations. Outside of school, Ashley enjoys graphic design, playing soccer, and photography.

Makoto Take

VP of Operations

Makoto is a fourth-year undergraduate student at UW, pursuing a BS in Mathematics as well as minors in Entrepreneurship and Neural Computation and Engineering. For the past three years, Makoto has been a member of the American Marketing Association where he served as VP of Student Development and VP of Sponsorship. He is also a member of the Phi Kappa Psi fraternity, where he has held five leadership roles including Director of Community Service, Head of Alumni Relations, and Head of Public Relations. As a devout futurist, Makoto looks to join the startup boom in Seattle and ultimately start a company based on computer-brain interface technology for health and mental illness applications.

Danielle Faivre

VP of Finance

Danielle is a Genome Sciences Ph.D. student in the MacCoss Lab. Her research involves using quantitative proteomics approaches to study neurodegenerative diseases by analyzing protein structure, turnover, and aggregation in cerebrospinal fluid and brain tissue. Before joining the MacCoss Lab, Danielle received a B.S. in Biochemistry at the University of Notre Dame and worked as an undergraduate researcher under Dr. Norman Dovichi. At UW, she has been part of the Bioscience Careers Seminar Committee and the CoMotion Innovation Development Intern Program. From these experiences, Danielle has become passionate about introducing undergraduate and graduate students to new opportunities and alternative careers in STEM fields. In her free time, she enjoys bouldering, playing soccer, and dancing at Zumba and Oula classes.

Please reload


Ron Howell

Ron Howell is the chief executive officer of the Washington Research Foundation, one of the nation’s top-ranked technology transfer organizations. After joining WRF in 1989, Ron led the organization through a major expansion, and stewarded WRF through its growth in assets from $13 million to $250 million. In 1994, the WRF leveraged staff expertise in evaluating research and intellectual property, and established WRF Capital, a return-on-investment mission, early-stage venture capital organization.

A renaissance man with a passion for science, jazz, photography and riding motorcycles, Ron is well-known to UW deans and academic leaders in the College of Engineering, the School of Medicine and the College of Arts & Sciences, where his strategic thinking has helped hone out-of-the-box ideas into commercializable technology. Ron has served on a number of boards at the University of Washington, Washington State University, Fred Hutchinson Cancer Research Center and The W Fund.

Brad Roberts

Brad Roberts is Senior Vice President and co-head of the Innovation Group at Xinova.  Brad is responsible for managing Xinova’s technical staff, its worldwide network of inventors, innovators, and commercializers, sets portfolio strategy, and liaises with each client’s technical team. Brad was responsible for starting Xinova’s operations in Israel. He joined Xinova's predecessor in 2010 as Technical Assistant to the Fund’s Executive VP, helping to implement and optimize programs in global invention sourcing.


Brad has a PhD from the University of Washington’s Department of Materials Science and Engineering in the synthesis and characterization of transition-metal-doped-oxide semiconductors for use in spin-based electronics. While at UW, Brad also completed a Technology Entrepreneurship Certificate at the Foster School of Business and earned a Washington Research Foundation Capital Gates Foundation Fellowship in Technology Commercialization. As President of the UW Science and Engineering Business Association, he facilitated programs to introduce technical students to the world of entrepreneurship and venture capital.


As an undergraduate, Brad was president of a ski touring club, co-founded a student-run engineering consulting business to utilize on-campus characterization tools, and established the campus chapter of the Alpha Sigma Mu materials engineering honor society. Undergraduate internships included both the Hardware Engineering and Product Design groups at Apple, as well as Software Engineering group at Qualcomm. He is currently a member of the Engineering Advisory Board at California Polytechnic State University (Cal Poly). 


Brad and his wife, who were married while on a school-building trek in Nepal, have since helped raise tens of thousands of dollars for additional schools and infrastructure repairs in earthquake-damaged Nepali villages.

Amy Sallin

Amy Sallin is director of the Buerk Center for Entrepreneurship in the UW’s Foster School of Business. With over 18 years in higher education, her background includes academic marketing, fundraising, relationship building, and program development, both at UW and Portland State University. Amy discovered her passion for entrepreneurship during a stint in Silicon Valley in the early 1980s, and has channeled that interest into helping students grow into entrepreneurs and change-makers. She’s been working with student entrepreneurs and the Seattle startup community for over seven years.

Jeff Chamberlain

Jeff Chamberlain works in Business Development at Seattle-based Pacific Biomarkers, supporting the biotech, pharma, and diagnostic industries in the development of their drug or diagnostic products. Prior to Pacific Biomarkers, Dr. Chamberlain worked for Zwitter Technology as Project Leader and Manager of Business Development, working toward the commercialization of a polymeric coating technology with applications in many fields including medicine, medical devices, and marine coatings. 

Dr. Chamberlain earned his Ph.D. in Bioengineering at the University of Washington, Seattle, where he leveraged multiple biosensing modalities to study bacterial binding and biomolecular interaction analysis. He concurrently obtained the Technology Entrepreneurship Certificate from the UW Foster School of Business and served as president of the UW Science & Engineering Business Association (SEBA). He is a frequent volunteer in the Seattle life sciences business community, primarily through his involvement with the industry trade association, Life Science Washington.

Brian Fabien

Professor Fabien joined the University of Washington in 1993 and is currently the Associate Dean for Academic Affairs in the College of Engineering. He is the Director of the Dynamic Systems Modeling and Controls Laboratory. Professor Fabien also directs the University of Washington EcoCAR program.

Christina Chan

Christina Chan is a corporate attorney with a focus on mergers & acquisitions, equity financings and other significant business transactions. She has significant experience managing deals in the health care and health tech industry. Christina also has extensive experience counseling technology companies in a variety of transactions including sell-side, buy-side, joint ventures, strategic investments, and equity financings.

Please reload